Zebrafish Candida Infection Models
Disease Models
CBpromise

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE
CONTACT US TO ORDER

Zebrafish Candida Infection Models

Introduction Model Details Phenotypic Evaluation Applications Study Examples

Introduction

Candida infection, or candidiasis, is caused by pathogenic Candida species, with Candida albicans being a major cause of mucosal and invasive fungal disease. Clinical manifestations range from oral and genital mucosal infections to candidemia and disseminated candidiasis. Invasive disease is particularly important in critically ill and immunocompromised patients, including individuals receiving intensive medical treatment, undergoing transplantation, or exposed to prolonged antimicrobial or immunosuppressive therapy. Once Candida enters the bloodstream, it can disseminate to multiple organs and cause life-threatening systemic infection. A major feature of C. albicans pathogenicity is its ability to switch between yeast and filamentous hyphal forms, which contributes to tissue invasion and virulence.

Current treatment relies primarily on azoles, echinocandins, and amphotericin B, but antifungal resistance, recurrent infection, and limited therapeutic options remain important challenges. Zebrafish provide a complementary vertebrate system for investigating Candida pathogenesis and host defense. Published models have reproduced dose-dependent mortality, fungal dissemination, yeast-to-hypha transition, and interactions with macrophages and neutrophils. Transparent larvae further enable longitudinal imaging of fungal growth and immune-cell behavior, supporting mechanistic studies and in vivo antifungal screening.

Why Zebrafish?

  • Live Infection Imaging: Transparent larvae enable direct visualization of fungal growth and immune-cell interactions.
  • Innate Immunity: Macrophage and neutrophil responses can be monitored in vivo.
  • Fungal Morphogenesis: Yeast-to-hypha transition can be followed during infection.
  • Screening Compatible: Small size and scalable handling support in vivo antifungal evaluation.

Available Zebrafish Disease Models

The Candida albicans infection model is the primary and most extensively characterized configuration, complemented by mucosal, phagocyte-interaction, virulence, and treatment models:

Model Name Induction Method Features
C. albicans Disseminated Infection Model Microinjection of C. albicans into zebrafish larvae. Established model for systemic fungal infection, virulence, fungal dissemination, and host defense.
C. albicans Mucosal Infection Model Direct injection of C. albicans into the swimbladder. Models localized mucosal infection and enables visualization of epithelial–immune–fungal interactions.
Phagocyte–Candida Interaction Model C. albicans infection in immune-cell reporter zebrafish. Enables real-time analysis of macrophage and neutrophil recruitment, phagocytosis, and fungal growth.
Candida Virulence Model Infection with wild-type or genetically modified C. albicans strains. Supports comparative analysis of fungal virulence, morphogenesis, and immune evasion.
Antifungal Treatment Model Candida infection followed by compound or antifungal treatment. Enables evaluation of survival, fungal burden, fungal morphology, and host-response changes.

Phenotypic Evaluation

Infection Progression

  • Survival and mortality kinetics
  • Infection-site expansion
  • Fungal dissemination
  • Disease progression over time

Fungal Burden & Morphology

  • Fungal burden at defined time points
  • Yeast-to-hypha transition
  • Hyphal extension and filamentation
  • Fungal localization and tissue invasion

Innate Immune Response

  • Macrophage recruitment
  • Neutrophil recruitment
  • Phagocytosis of fungal cells
  • Phagocyte–fungus interactions
  • Inflammatory gene responses

Therapeutic Response

  • Increased survival following treatment
  • Reduced fungal burden
  • Suppression of hyphal development
  • Improved infection-associated pathology
  • Modulation of host inflammatory responses

Tissue & Pathological Changes

  • Infection-associated tissue damage
  • Histopathological changes
  • Hemorrhage or edema
  • Local inflammatory responses

Key Applications

  • Antifungal Drug Screening: Evaluate the in vivo activity of candidate compounds against C. albicans infection.
  • Candida Virulence Studies: Compare fungal strains and genetic variants to identify determinants of pathogenicity.
  • Host–Pathogen Interaction Studies: Investigate interactions between Candida cells and macrophages, neutrophils, and other host components.
  • Fungal Morphogenesis Studies: Characterize the transition from yeast to hyphal growth and its contribution to infection progression.
  • Innate Immune Mechanism Studies: Examine phagocyte recruitment, phagocytosis, oxidative defense, and fungal immune evasion.

Study Examples

A zebrafish swimbladder model for mucosal candidiasis. The researchers developed a localized mucosal candidiasis model by directly introducing C. albicans into the swimbladder of juvenile zebrafish. This approach established a defined mucosal infection site where epithelial barriers, fungal growth, and innate immune responses could be examined in vivo.

Swimbladder injection establishes a localized Candida infection for real-time analysis of mucosal host defenseFig. 1. Swimbladder injection establishes a localized Candida infection for real-time analysis of mucosal host defense (Gratacap RL, Bergeron AC, et al., 2014).

Zebrafish Candida Infection Models

Establish and evaluate zebrafish models of Candida infection for antifungal efficacy studies, fungal virulence research, and host–pathogen interaction studies. Model configurations can be tailored to systemic or localized infection and evaluated using survival, fungal burden, morphogenesis, immune-cell responses, and treatment-associated phenotypes.

Reference

  1. Gratacap RL, Bergeron AC, et al. Modeling Mucosal Candidiasis in Larval Zebrafish by Swimbladder Injection. Journal of Visualized Experiments 2014(93), e52182.

For research use only. Not intended for any clinical use.

Quick Inquiry

Tell Us What Happened

Please contact us if you have questions about our company, our products, or general enquiries.

Please use the form.